Aamal Announces Exclusive Agreement Between Aamal Medical and Leo Cancer Care for Advanced Radiotherapy Technologies across the MENA Region
Aamal Company Q.P.S.C. Announces Exclusive Agreement Between Aamal Medical and Leo Cancer Care for Advanced Radiotherapy Technologies across the MENA Region
Agreement strengthens Aamal Medical’s specialised healthcare portfolio and supports access to innovative cancer treatment solutions
Doha, Qatar –1 Nov 2026: Aamal Company Q.P.S.C., one of Qatar’s leading diversified companies, announces that its subsidiary, Aamal Medical, a leading medical equipment supplier in Qatar, has signed a representation agreement with Leo Cancer Care, a pioneer in upright radiotherapy solutions, appointing Aamal Medical as the exclusive distributor of its technologies in the Middle East and North Africa (MENA).
With more than 50 years of experience supplying medical equipment to Qatar’s healthcare sector, Aamal Medical will represent Leo Cancer Care’s innovative upright radiotherapy systems. The agreement expands Aamal Medical’s portfolio of specialized healthcare technologies and supports Aamal’s strategy to develop its healthcare business through partnerships with international innovators.
Leo Cancer Care’s technology offers an alternative approach to radiotherapy by positioning patients upright while keeping the treatment beam fixed. Its Marie solution for particle therapy has received US Food and Drug Administration (FDA) 510(k) clearance and CE marking and has been used to deliver its first patient treatments. The company is also developing Grace, its next-generation upright photon therapy solution, with the aim of extending this approach to conventional radiotherapy.
Gokhan Ozkan, General Manager of Aamal Medical, commented: “We are pleased to partner with Leo Cancer Care to bring its innovative upright radiotherapy technologies to our markets. Aamal Medical has long supported national institutions in Qatar in their efforts to reduce the burden of cancer. Upright treatment options have the potential to improve access to radiotherapy while making the treatment experience more patient-centred and humane. This partnership reflects our commitment to equipping healthcare institutions with advanced solutions. By combining our longstanding market experience and relationships with Leo Cancer Care’s technological expertise, we will strengthen our oncology offering and create new opportunities for sustainable growth.”
Miha Ulcar, Director of Sales EMEA at Leo Cancer Care, commented: “We are excited to partner with Aamal Medical, whose longstanding reputation and reach within Qatar’s healthcare sector will be invaluable as we introduce our upright radiotherapy solutions to the region.”
Through this partnership, Aamal Medical aims to build relationships with healthcare providers exploring the adoption of upright radiotherapy and develop its presence in specialized cancer treatment technologies. The
agreement also provides a platform to pursue regional opportunities, supporting the continued expansion of Aamal’s healthcare operations.
#Ends #
Notes to the Editor
About Aamal Medical:
Aamal Medical, a fully owned subsidiary of Aamal Company Q.P.S.C., is a leading medical equipment supplier in Qatar. The company has exclusive distribution agreements with several leading international medical equipment suppliers.
Aamal Medical also provides consultancy services focused on the development of operating theatres and the installation of hospital information systems.
The company offers a holistic range of medical equipment for hospitals and has recently expanded its product offerings to endoscopy, Ambulance and Emergency Medical Services (EMS) and Radio Frequency Identification (RFID) tracking.
About Aamal Company Q.P.S.C
Aamal is one of the region’s most diversified conglomerates and has been listed on the Qatar Stock Exchange since December 2007. As of 29 of October 2026, the Company had a market capitalisation of QAR 4.1 bn (US$ 1.1 bn).
Aamal’s operations are widely diversified and comprise 32 active business units (subsidiaries and joint ventures) with market leading positions in the key industrial, retail, property, managed services, and medical equipment and pharmaceutical sectors, thereby offering investors a high quality and balanced exposure to Qatar’s wider economic growth and development.
For further information on Aamal Company, please refer to the corporate website: http://www.aamal.qa
About Leo Cancer Care
Leo Cancer Care is redefining the way radiotherapy is delivered through upright patient positioning and imaging solutions designed to improve patient experience, comfort, and efficiency in cancer treatment.
For Further information contact Aamal Company:
[email protected]
